Tenapanor
1 known investors
IBSRELA is a prescription medication containing tenapanor designed to treat irritable bowel syndrome with constipation (IBS-C) in adults by reducing constipation and abdominal pain. The drug works by increasing intestinal water retention, supporting gut lining integrity, and reducing pain-sensing nerve sensitivity.
Investors · 1
Frequently asked questions
- What does Tenapanor do?
- IBSRELA is a prescription medication containing tenapanor designed to treat irritable bowel syndrome with constipation (IBS-C) in adults by reducing constipation and abdominal pain. The drug works by increasing intestinal water retention, supporting gut lining integrity, and reducing pain-sensing nerve sensitivity.
- Who are Tenapanor's investors?
- Tenapanor's investors include HEALTHCARE ROYALTY PARTNERS.